{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:27:36Z","timestamp":1791016056308,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.ymgme.2003.08.025","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T15:56:24Z","timestamp":1068220584000},"page":"419-425","source":"Crossref","is-referenced-by-count":11,"title":["Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria"],"prefix":"10.1016","volume":"80","author":[{"given":"P","family":"Parvex","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dziarmaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Goodyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2003.08.025_BIB1","first-page":"4909","article-title":"Cystinuria","volume":"vol. III","author":"Palacin","year":"2001"},{"key":"10.1016\/j.ymgme.2003.08.025_BIB2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0272-6386(12)80602-0","article-title":"Etiology and treatment of urolithiasis","volume":"18","author":"Pak","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000020659","article-title":"The molecular basis of cystinuria: an update","volume":"8","author":"Goodyer","year":"2000","journal-title":"Exp. Nephrol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI102996","article-title":"The pathogenesis of cystinuria. Polarographic studies of the metabolism of sulfur-containing aminoacids","volume":"33","author":"Dent","year":"1954","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1464-410X.1955.tb03486.x","article-title":"Studies on the treatment of cystinuria","volume":"27","author":"Dent","year":"1955","journal-title":"Brit. J. Urol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0022-3476(05)83537-1","article-title":"Prospective analysis and classification of patients with cystinuria identified in a newborn screening program","volume":"122","author":"Goodyer","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1523-1755.1998.00957.x","article-title":"Cystinuria subtype and the risk of nephrolithiasis","volume":"54","author":"Goodyer","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB8","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0022-5347(01)65451-X","article-title":"Medical treatment of cystinuria: results of contemporary clinical practice","volume":"156","author":"Chow","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ki.1990.20","article-title":"Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients","volume":"37","author":"Martens","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0009-8981(87)90180-X","article-title":"Determination of urinary cystine for monitoring anticystinuric therapy","volume":"165","author":"Backer","year":"1987","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2003.08.025_BIB11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00003088-198713050-00003","article-title":"Clinical pharmacokinetics of d-penicillamine","volume":"13","author":"Neter","year":"1978","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB12","first-page":"F321","article-title":"d-Penicillamine and the transport of l-cystine by rat and human renal cortical brush-border membrane vesicles","author":"Furlong","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0022-5347(17)45188-3","article-title":"Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine","volume":"136","author":"Charles","year":"1986","journal-title":"J. Urol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00003088-198510050-00001","article-title":"Clinical pharmacokinetics of angiotensin converting enzyme inhibitors: a review","volume":"10","author":"Kubo","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0272-6386(12)80396-9","article-title":"Successful treatment of cystinuria with captopril","volume":"21","author":"Perazella","year":"1993","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0041-008X(89)90338-4","article-title":"Determination and metabolism of dithiol chelating agents","volume":"97","author":"Maiorini","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB17","first-page":"313","article-title":"Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism","volume":"124","author":"Liebelt","year":"1994","journal-title":"Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/taap.1999.8807","article-title":"Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure","volume":"161","author":"Cremin","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.147.8.1409","article-title":"Captopril reduces urinary cystine excretion in cystinuria","volume":"147","author":"Sloand","year":"1987","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-5347(01)67256-2","article-title":"Clinical effect of captopril on the formation and growth of cystine calculi","volume":"154","author":"Cohen","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB21","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)39146-2","article-title":"Effect of captopril on urinary cystine excretion in homozygous cystinuria","volume":"142","author":"Streem","year":"1989","journal-title":"J. Urol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0022-3476(97)70285-3","article-title":"Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus ethylenediaminetetraacetic acid in children with lead poisoning","volume":"130","author":"Besunder","year":"1996","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2003.08.025_BIB23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1081\/CLT-100100945","article-title":"Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentration","volume":"38","author":"Chisolm","year":"2000","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.ymgme.2003.08.025_BIB24","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM200105103441902","article-title":"The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead","volume":"344","author":"Walter","year":"2001","journal-title":"N. Engl. J. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719203001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719203001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T08:22:42Z","timestamp":1550391762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719203001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1096719203001896"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2003.08.025","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}